Navigation Links
Haemonetics Reports 8% Revenue Growth for Second Quarter of Fiscal 2012, Adjusted Earnings Per Share of $0.72 and Updates Previously Provided Full Year Earnings Guidance
Date:10/31/2011

FY12 and FY11Three Months Ended10/1/201110/2/2010Non-GAAP gross profitGAAP gross profit$89,949$87,755Restructuring and transformation costs1,381-Non-GAAP gross profit$91,330$87,755Non-GAAP R&DGAAP R&D$10,350$7,954Restructuring and transformation costs(1,356)-Non-GAAP R&D$8,994$7,954Non-GAAP S,G&AGAAP S,G&A$62,613$52,790Restructuring and transformation costs(5,792)(1,120)Non-GAAP S,G&A$56,821$51,670Non-GAAP operating expensesGAAP operating expenses$71,383$58,850Restructuring and transformation costs(7,148)(1,120)Contingent consideration income1,5801,894Non-GAAP operating expenses$65,815$59,624Non-GAAP operating income GAAP operating income$18,566$28,905Restructuring and transformation costs8,5291,120Contingent consideration income(1,580)(1,894)Non-GAAP operating income $25,515$28,131Non-GAAP income before taxesGAAP income before taxes$19,011$29,159Restructuring and transformation costs8,5291,120Contingent consideration income(1,580)(1,894)Non-GAAP income before taxes$25,960$28,385Non-GAAP net incomeGAAP net income$13,880$21,338Restructuring and transformation costs8,5291,120Contingent consideration income(1,580)(1,894)Tax benefit associated with non-GAAP items(2,164)(467)Non-GAAP net income$18,665$20,097Non-GAAP net income per common share assuming dilutionGAAP net income per common share assuming dilution$0.54$0.85Non-GAAP items after tax per common share assuming dilution$0.18($0.05)Non-GAAP net income per common share assuming dilution$0.72$0.80Presented below are additional Constant Currency performance measures.  We measure different components of our business at constant currency.  We believe this information is useful for investors because it allows for an evaluation of the Company without the effect of changes in foreign exchange rates.  These results convert our local foreign currency operating results to the US Dollar at constant exchange rates of $1.20 per Euro, and 110 Yen to the $1.00.  They also exclude the re
'/>"/>
SOURCE Haemonetics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Haemonetics Sets Date for Second Quarter Fiscal Year 2012 Earnings Release: October 31, 2011
2. Haemonetics Sets Date for Fourth Quarter Fiscal Year 2011 Earnings Release: May 2, 2011
3. Haemonetics to Present at J.P. Morgan Healthcare Conference
4. Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers
5. Pacira Pharmaceuticals, Inc. Reports Third Quarter 2011 Financial Results
6. ReportsnReports - Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020
7. HeartWare International Reports Third Quarter 2011 Revenues of $21.3 Million; 54% Increase From $13.8 Million in Third Quarter 2010
8. Uroplasty Reports Fiscal Second Quarter 2012 Financial Results
9. Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2011
10. ERT Reports Third Quarter 2011 Operating Results
11. CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... -- RESMED INC. (NYSE: RMD ) today announced that ... June 30, 2014 results on Thursday, July 31, 2014, after ... with ResMed,s results will be issued after 1:00 p.m. US ... discuss operating results and future outlook. The earnings ... Time and the live webcast of the call can be ...
(Date:7/10/2014)... Quebec , July 10, 2014  Valeant Pharmaceuticals ... VRX) today announced it has completed the sale to ... and Dysport owned or held by Valeant for $1.4 ... with Nestle S.A, which recently completed its acquisition of ... the divestiture of our products to a company that ...
(Date:7/10/2014)... CAESAREA, Israel , July 10, 2014 /PRNewswire/ ... Dario™ Diabetes Management Solution, today announced the appointment ... an independent member of its Board of Directors. ... of legal and business experience to LabStyle as ... director, and legal and corporate governance expert. He ...
Breaking Medicine Technology:ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4
... Dec. 11 As Warner Chilcott plc (Nasdaq: ... global branded prescription pharmaceuticals business of The Procter & ... Acquisition"), constituted a change of control under a global ... P&G subsidiary acquired by Warner Chilcott and Sanofi-Aventis U.S. ...
... , IRVINE, Calif., Dec. 11 PRO-DEX, INC. (Nasdaq: ... Annual Shareholders Meeting held on December 4, 2009. At the ... Healey, David Holder and Mark Murphy as directors; (ii) approved the ... split if it should elect to do so at any time ...
Cached Medicine Technology:Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 2Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 3Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 4Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4
(Date:7/13/2014)... published today in The Lancet Neurology ... the long term neurological problems that repeated concussions ... common form of sports-related traumatic brain injury (TBI), ... include dementia, amyotrophic lateral sclerosis, and other neurological ... perhaps more concerning, is that even when the ...
(Date:7/13/2014)... research in Nature Genetics identifies a ... that causes eosinophillic esophagitis (EoE), opening up potential ... food allergy. , EoE is a chronic ... triggered by allergic hypersensitivity to certain foods and ... cells called eosinophils (part of the body,s immune ...
(Date:7/13/2014)... 13, 2014 The North American water storage ... 2013 to $5,450 million by 2018, at a CAGR of ... is expanding at a rapid pace in North America. The ... laws on water & wastewater storage and collection, and the ... market is expanding at a healthy rate in Canada, and ...
(Date:7/13/2014)... According to a new market ... by Component (processor, GPU, DSP, connectivity), Technology Node ... Geography - Forecast and Analysis to 2014-2020", published ... Computing Market is expected to reach $61.70 Billion ... from 2014 to 2020. , Browse 71 market ...
(Date:7/13/2014)... July 13, 2014 Athletes with a ... period from concussions, according to research presented today at ... ) Annual Meeting. The research marks the first of ... on the known physical events that occur after a ... a long allele in the (GT)n genotype were four ...
Breaking Medicine News(10 mins):Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 2Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 3Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 2Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2
... March Issue of Nicotine and Tobacco Research Analyzes Trends, ... date, the majority of research conducted about tobacco use ... heavy smoking. The March 2009 issue of ... light and intermittent smoking. Several of the nation,s preeminent ...
... Dr. Matt Regulski --FORT WORTH, Texas, March 20 ... Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), ... 09 on March 19-21, 2009 at the Renaissance ... considered the premier international multidisciplinary diabetic foot conference ...
... DICK GEPHARDT SERVES ON MMR INFORMATION SYSTEMS, ... MMR Information Systems, Inc. (OTC Bulletin ... subsidiary, MyMedicalRecords, Inc. (collectively, "MMR") provides consumer-controlled ... and electronic safe deposit box storage solutions ...
... well, study says there,s no rush to abandon standard care ... of maggots to treat leg ulcers is similar to standard ... to British researchers. , Debridement (removal of dead tissue ... common part of treatment for leg ulcers, chronic wounds most ...
... SOUTH EASTON, Mass., March 20 Pressure BioSciences, Inc. ... today provided an update on various corporate activities, including ... Innovation Research ("SBIR") Grant from the National Institutes of ... of the Harvard School of Public Health ...
... Nasdaq: SHPGY ), the global specialty biopharmaceutical ... (39) lots of the ADHD patch DAYTRANA (the lots ... below). Shire is taking this action because some ... specification, and as a result, patients and caregivers could ...
Cached Medicine News:Health News:New Analysis: Light and Intermittent Smokers Overlooked in Traditional Tobacco Research 2Health News:New Analysis: Light and Intermittent Smokers Overlooked in Traditional Tobacco Research 3Health News:New Analysis: Light and Intermittent Smokers Overlooked in Traditional Tobacco Research 4Health News:Wound Management Technologies Exhibits at Premier International Diabetic Foot Conference DFCon 09 2Health News:Wound Management Technologies Exhibits at Premier International Diabetic Foot Conference DFCon 09 3Health News:Former House Democratic Leader Richard A. Gephardt to Join MMR Initiative to Promote Immediate Use of Personal Health Records 2Health News:Former House Democratic Leader Richard A. Gephardt to Join MMR Initiative to Promote Immediate Use of Personal Health Records 3Health News:Former House Democratic Leader Richard A. Gephardt to Join MMR Initiative to Promote Immediate Use of Personal Health Records 4Health News:Maggots as Good as Gel in Leg Ulcer Treatments 2Health News:Pressure BioSciences, Inc. Provides Corporate Update 2Health News:Pressure BioSciences, Inc. Provides Corporate Update 3Health News:Pressure BioSciences, Inc. Provides Corporate Update 4Health News:Pressure BioSciences, Inc. Provides Corporate Update 5Health News:Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced 2Health News:Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced 3Health News:Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced 4Health News:Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced 5
Inquire...
Inquire...
... The Micro MB for Microhematocrit meets or ... the NCCLS "Standard Procedure for the Determination ... Method" as well as other U.S. and ... Microhematocrit determinations, order Cat. No. 3411 or ...
... two centrifuges -- the world's most popular ... in one reliable, quiet, compact unit. It ... two separate centrifuges!, For your microcentrifuge needs, ... supplies you with the MicroMB centrifuge, microcentrifuge ...
Medicine Products: